EcoDrugPlus

Prostaglandin E Receptor 3

Ensembl ID : ENSMAUG00000011005
Gene Symbol: PTGER3
3 Cross references
194 Possible Orthologues:

Prostaglandin E Receptor 4

Ensembl ID : ENSMAUG00000014264
Gene Symbol: PTGER4
4 Cross references
274 Possible Orthologues:

Prostaglandin F Receptor

Ensembl ID : ENSMAUG00000013922
Gene Symbol: PTGFR
4 Cross references
195 Possible Orthologues:

Prostaglandin I2 Receptor

Ensembl ID : ENSMAUG00000011407
Gene Symbol: PTGIR
3 Cross references
187 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 1

Ensembl ID : ENSMAUG00000006589
Gene Symbol: PTGS1
3 Cross references
256 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 2

Ensembl ID : ENSMAUG00000018762
Gene Symbol: PTGS2
4 Cross references
237 Possible Orthologues:

Proteasome (Prosome, Macropain) 26s Subunit, Atpase 2

Ensembl ID : ENSMAUG00000008073
Gene Symbol: PSMC2
1 Cross references
223 Possible Orthologues:

Proteasome (Prosome, Macropain) 26s Subunit, Non-Atpase, 2

Ensembl ID : ENSMAUG00000014316
Gene Symbol: PSMD2
1 Cross references
222 Possible Orthologues:

Proteasome 20s Subunit Alpha 2

Ensembl ID : ENSMAUG00000009719
Gene Symbol: PSMA2
4 Cross references
246 Possible Orthologues:

Proteasome 20s Subunit Alpha 4

Ensembl ID : ENSMAUG00000011209
Gene Symbol: PSMA4
4 Cross references
241 Possible Orthologues:

Proteasome 20s Subunit Alpha 5

Ensembl ID : ENSMAUG00000019226
Gene Symbol: PSMA5
4 Cross references
209 Possible Orthologues:

Proteasome 20s Subunit Alpha 6

Ensembl ID : ENSMAUG00000019916
Gene Symbol: PSMA6
4 Cross references
272 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).